The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Diagnosis of narcolepsy type 1 or narcolepsy type 2
Nightmare frequency of ≥1 times per week
Age 18 or older
Able to speak, read, and write in English
Currently engaged in trauma- or sleep-related psychotherapy
Previous behavioral treatment for nightmares
Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
Untreated moderate-severe sleep apnea